Related Experiment Video
Updated: Mar 23, 2026

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
Published on: February 9, 2024
Multidrug Resistant Shigella flexneri Infection Simulating Intestinal Intussusception.
Srirangaraj Sreenivasan1, Arunava Kali1, Jothimani Pradeep1
1Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Puducherry, India.
Shigella enteritis, a significant global health issue, requires monitoring due to rising antibiotic resistance. This case highlights successful ceftriaxone treatment for multidrug-resistant Shigella flexneri ileitis in an infant.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Gastroenterology
Background:
- Shigella enteritis is a major cause of mortality and morbidity globally.
- Emerging multidrug resistance in Shigella species poses a significant public health threat.
- Constant monitoring of Shigella resistance patterns is crucial for effective treatment.
Observation:
- A case of segmental ileitis in an infant presented with symptoms mimicking intussusception.
- The ileitis was caused by non-ESBL producing multidrug-resistant Shigella flexneri.
- This specific Shigella strain exhibited resistance to multiple antibiotics.
Findings:
- Multidrug-resistant Shigella flexneri was identified as the causative agent of ileitis.
- The infant's condition clinically resembled intussusception.
- Effective treatment was achieved using ceftriaxone.
Implications:
- This case underscores the importance of considering resistant bacterial infections in pediatric gastrointestinal emergencies.
- Ceftriaxone can be an effective therapeutic option for non-ESBL producing multidrug-resistant Shigella flexneri infections.
- Further research into antimicrobial resistance patterns in Shigella is warranted to guide clinical practice.
Related Concept Videos
Bacterial Gastroenteritis
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

